A comparison of two doses of nizatidine versus placebo in the treatment of reflux oesophagitis

Alimentary Pharmacology and Therapeutics

Volumn 4, Issue 2, 1990, Pages 201-211

  Quik, R F P ^a   Cooper, M J ^a   Gleeson, M ^a   Hentschel, E ^a   Schuetze, K ^a   Kingston, R D ^a   Mitchell, M ^a  

^a Exeter Hospital   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

NIZATIDINE;

ADULT; AGED; ARTICLE; DRUG COMPARISON; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; REFLUX ESOPHAGITIS;

EID: 0025003193     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2036.1990.tb00465.x     Document Type: Article

References (47)

1. Scarpignato Pharmacological bases of the medical treatment of gastro-oesophageal reflux disease Dig Dis 1988 10.1159/000171190 6 117
2. Richter Gastro-oesophageal reflux disease. Pathogenesis, Diagnosis, Therapy 1985 221
3. Nebel Symptomatic gastroesophageal reflux: incidence and precipitating factor Dig Dis Sci 1976 21 955
4. Acomb Reflux oesophagitis and hiatus hernia Pharm J 1988 625
5. Bovero Shortterm treatment of reflux oesophagitis with ranitidine 300 mg; nocte Italian multicentre study Hepato-gastroenterol 1987 34 155
6. Koelz Healing and relapse of refluxoesophagitis during treatment with ranitidine Gastroenterology 1986 10.1016/S0016-5085(86)80017-8 91 1198
7. Berstadt The Clinical use of ranitidine 1982 297
8. Sherbaniuk The clinical use of ranitidine 1982 283
9. Wesdorp The clinical use of ranitidine 1982 293
10. Brogden Ranitidine: A review of its pharmacology and therapeutic use in peptic ulcer disease and other allied diseases Drugs 1982 10.2165/00003495-198224040-00002 24 267
11. Boyd Review of ulcer treatment: role of ranitidine J Clin Gastroenterol 1983 10.1097/00004836-198312001-00013 5 Suppl. 1 133
12. Sandmark Omeprazole or ranitidine in the treatment of reflux oesophagitis Scand J Gastroenterol 1988 10.3109/00365528809093923 23 625
13. Lehtola Ranitidine, 150 mg three times a day, in the treatment of reflux oesophagitis Scand J Gastroenterol 1986 10.3109/00365528609034643 21 175
14. Bright-Asare Cimetidine, metoclopramide, or placebo in the treatment of symptomatic gastroesophageal reflux J Clin Gastroenterol 1980 10.1097/00004836-198006000-00008 2 149
15. Behar Cimetidine in the treatment of symptomatic gastroesophageal reflux. A double blind controlled trial Gastroenterology 1978 10.1016/0016-5085(78)90778-3 74 441
16. Powell-Jackson Effect of cimetidine in symptomatic gastroesophageal reflux Lancet 1978 10.1016/S0140-6736(78)91802-0 ii 1068
17. Petrokubi Cimetidine versus antacid in scleroderma with reflux oesophagitis Gastroenterology 1979 10.1016/0016-5085(79)90223-3 77 691
18. Fiasse Controlled trial of cimetidine in reflux oesophagitis Dig DisSci 1980 25 750
19. Bennet Cimetidine in gastroesophageal reflux Digestion 1983 10.1159/000198884 26 166
20. Ferguson Cimetidine in treatment of reflux oesophagitis with peptic stricture Br Med J 1979 10.1136/bmj.2.6188.472 2 472
21. Wesdorp Treatment of oesophagitis with ranitidine Gut 1983 10.1136/gut.24.10.921 24 921
22. Rohner Zwei oder eine tagesdosis ranitidine zur behandlung der refluxoesophagitis Z Gastroenterologie 1986 24 396
23. Festen Cimetidine in the treatment of severe ulcerative refluxoesophagitis; results of an 8-week double blind study and of subsequent long-term maintenance treatment Neth J Med 23 237
24. Price Nizatidine: A preliminary review of its pharmacodynamic properties, and its therapeutic use in peptic ulcer disease Drugs 1988 10.2165/00003495-198836050-00002 36 21
25. Dammann Nocturnal acid suppression with a new H2 receptor antagonist: nizatidine Hepatogastroenterol 1986 33 217
26. Lanzon-Miller 24-hour intragastric acidity and plasma gastrin concentration in healthy volunteers taking nizatidine 150 mg, nizatidine 300 mg ranitidine 300 mg or placebo at 21.00 h Gut 1988 10.1136/gut.29.10.1364 29 1364
27. Delle Evidence that the length of gastric acid inhibition is a co-factor in regulating gastrin release in man Scand J Gastroenterol
28. Knadler Absorption studies of the H2-blocker nizatidine Clin Pharm Ther 1987 10.1038/clpt.1987.190 42 514
29. Knadler Nizatidine, an H2-blocker, its metabolism and disposition in man Drug Metab Dispos 1986 14 175
30. Klotz Lack of effect of nizatidine on drug metabolism Scand J Gastroenterol 1987 10.3109/00365528709094481 122 Suppl. 136 18
31. Secor Lack of effect of nizatidine on hepatic drug metabolism in man Br J Clin Pharmacol 1985 10.1111/j.1365-2125.1985.tb05136.x 20 710
32. Thiel An evaluation of the anti-androgen effects associated with H2 antagonist therapy Scand J Gastroenterol 1987 10.3109/00365528709094482 22 Suppl. 136 24
33. Borch Gastric endocrine cell hyperplasia and carcinoid tumours in pernicious anaemia Gastroenterology 1985 10.1016/0016-5085(85)90131-3 88 638
34. Harvey Multifocal gastrin carcinoid tumours, achlorhydria, and hypergastrinaemia Lancet 1985 10.1016/S0140-6736(85)91727-1 i 951
35. Borch Relations between circulating gastrin and endoctine cell proliferation in the atrophic gastric fundic mucosa Scand J Gastroenterol 1986 10.3109/00365528609003087 21 357
36. Ekman Omeprazole, book one 1985 20 Suppl. 108 53
37. Larsson Plasma gastrin and gastrin enterochromaf-fin-like cell activation and proliferation Gastroenterology 1986 10.1016/0016-5085(86)90938-8 90 391
38. Bovero Nizatidine in the short-term treatment of duodenal ulcer: an Italian multicenter study Hepatogastroenterology 1987 34 269
39. Dyck Treatment of duodenal ulceration in the United States Scand J Gastroenterol 1987 10.3109/00365528709094486 22 suppl. 136 47
40. Levendoglu Effect of nizatidine on duodenal ulcer healing IRCS Med Sci 1986 14 345
41. Levengodlu Nizatidine: a new histamine receptor blocker in the treatment of active duodenal ulcers Am J Gastroenterol 1986 81 1167
42. Pace Nizatidine and ranitidine in the short-term treatment of duodenal ulcer: a cooperative double-blind study of once-daily bedtime administration Am J Gastroenterol 1988 83 643
43. Simon and Members of the European Duodenal Ulcer Study Group. 300 mg nizatidine at night versus 300 mg ranitidine at night in patients with duodenal ulcer: a multicentre trial in Europe Scand J Gastroenterol 1987 10.3109/00365528709094488 22 Suppl. 136 61
44. Cerulli Nizatidine as maintenance therapy of duodenal ulcer disease in remission Scand J Gastroenterol 1987 10.3109/00365528709094490 22 Suppl. 136 79
45. Hentschel and Members of the European Nizatidine Maintenance Treatment Study Group. Nizatidine versus ranitidine in the prevention of duodenal ulcer relapse: six-month interim results of a European multicentre study Scand J Gastroenterol 1987 10.3109/00365528709094491 22 Suppl. 136 84
46. Naccaratto and Members of the European Nizatidine Gastric Ulcer Study Group. Nizatidine versus ranitidine in gastric ulcer disease: A European multicentre trial Scand J Gastroenterol 1987 10.3109/00365528709094489 22 Suppl. 136 71
47. Berges A comparison of two doses of nizatidine in reflux oesophagitis Z Gastroenterol 1989 27 156